CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A Review In oncology drug development, using biomarkers to select a study population more likely to benefit from a therapeutic effect is ...
Garching / Munich, Germany, August 19, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that further data on efficacy, safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback